136 related articles for article (PubMed ID: 30072056)
1. Using Epigenetic Tools to Investigate Antidepressant Response.
Fiori LM; Lin R; Ju C; Belzeaux R; Turecki G
Prog Mol Biol Transl Sci; 2018; 158():255-272. PubMed ID: 30072056
[TBL] [Abstract][Full Text] [Related]
2. Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response.
Fiori LM; Lopez JP; Richard-Devantoy S; Berlim M; Chachamovich E; Jollant F; Foster J; Rotzinger S; Kennedy SH; Turecki G
Int J Neuropsychopharmacol; 2017 Aug; 20(8):619-623. PubMed ID: 28520926
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic and epigenomic biomarkers of antidepressant response.
Belzeaux R; Lin R; Ju C; Chay MA; Fiori LM; Lutz PE; Turecki G
J Affect Disord; 2018 Jun; 233():36-44. PubMed ID: 28918100
[TBL] [Abstract][Full Text] [Related]
4. Noncoding RNAs in Depression.
Lin R; Turecki G
Adv Exp Med Biol; 2017; 978():197-210. PubMed ID: 28523548
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations.
Lisoway AJ; Zai CC; Tiwari AK; Kennedy JL
Neurosci Lett; 2018 Mar; 669():14-23. PubMed ID: 28063933
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of BDNF expression according to antidepressant response.
Lopez JP; Mamdani F; Labonte B; Beaulieu MM; Yang JP; Berlim MT; Ernst C; Turecki G
Mol Psychiatry; 2013 Apr; 18(4):398-9. PubMed ID: 22547115
[No Abstract] [Full Text] [Related]
7. The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review.
Webb LM; Phillips KE; Ho MC; Veldic M; Blacker CJ
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012861
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic Brain Network Biomarkers of Antidepressant Response: a Review.
Dunlop K; Talishinsky A; Liston C
Curr Psychiatry Rep; 2019 Aug; 21(9):87. PubMed ID: 31410661
[TBL] [Abstract][Full Text] [Related]
9. Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.
Helton SG; Lohoff FW
Pharmacogenomics; 2015; 16(5):541-53. PubMed ID: 25916524
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers predicting antidepressant treatment response: how can we advance the field?
Labermaier C; Masana M; Müller MB
Dis Markers; 2013; 35(1):23-31. PubMed ID: 24167346
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of microRNAs in major depressive disorder and its implication on diagnosis and therapeutic response.
Zhou L; Zhu Y; Chen W; Tang Y
J Affect Disord; 2021 May; 286():80-86. PubMed ID: 33714174
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?
Paoli C; Misztak P; Mazzini G; Musazzi L
Curr Neuropharmacol; 2022 Nov; 20(12):2267-2291. PubMed ID: 35105292
[TBL] [Abstract][Full Text] [Related]
13. Potential Use of MicroRNA for Monitoring Therapeutic Response to Antidepressants.
Belzeaux R; Lin R; Turecki G
CNS Drugs; 2017 Apr; 31(4):253-262. PubMed ID: 28290081
[TBL] [Abstract][Full Text] [Related]
14. Moving pharmacoepigenetics tools for depression toward clinical use.
Hack LM; Fries GR; Eyre HA; Bousman CA; Singh AB; Quevedo J; John VP; Baune BT; Dunlop BW
J Affect Disord; 2019 Apr; 249():336-346. PubMed ID: 30802699
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Modifications of Major Depressive Disorder.
Saavedra K; Molina-Márquez AM; Saavedra N; Zambrano T; Salazar LA
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527165
[TBL] [Abstract][Full Text] [Related]
16. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
17. Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment.
Frieling H; Tadić A
Int Rev Psychiatry; 2013 Oct; 25(5):572-8. PubMed ID: 24151802
[TBL] [Abstract][Full Text] [Related]
18. Major depression and its treatment: microRNAs as peripheral biomarkers of diagnosis and treatment response.
Lopez JP; Kos A; Turecki G
Curr Opin Psychiatry; 2018 Jan; 31(1):7-16. PubMed ID: 29076893
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in Major Depressive Disorder.
Fries GR; Zhang W; Benevenuto D; Quevedo J
Adv Exp Med Biol; 2019; 1118():175-190. PubMed ID: 30747423
[TBL] [Abstract][Full Text] [Related]
20. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.
Lam RW; Milev R; Rotzinger S; Andreazza AC; Blier P; Brenner C; Daskalakis ZJ; Dharsee M; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Geraci J; Giacobbe P; Feilotter HE; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; Liotti M; MacQueen GM; McAndrews MP; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Salomons TV; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Kennedy SH;
BMC Psychiatry; 2016 Apr; 16():105. PubMed ID: 27084692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
